Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Julphar
Teva
Citi
Fuji
McKesson
QuintilesIMS
Accenture

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,608,282

« Back to Dashboard

Which drugs does patent 7,608,282 protect, and when does it expire?

Patent 7,608,282 protects SANCUSO and is included in one NDA.

This patent has thirty-seven patent family members in thirty-one countries.
Summary for Patent: 7,608,282
Title:Transdermal granisetron
Abstract:Adhesive patches for the transdermal administration of granisetron, comprise an acrylic adhesive containing non-acidic nucleophilic moieties which substantially increase flux of granisetron across the skin.
Inventor(s): Altenschopfer; Peter (Ortenburg, DE), Watkinson; Adam Charles (Victoria, AU)
Assignee: Strakan International Limited (Hamilton, BM)
Application Number:10/544,259
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,608,282
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 7,608,282

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Kyowa Kirin SANCUSO granisetron FILM, EXTENDED RELEASE;TRANSDERMAL 022198-001 Sep 12, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,608,282

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0302662.2Feb 05, 2003
PCT Information
PCT FiledFebruary 05, 2004PCT Application Number:PCT/GB2004/000403
PCT Publication Date:August 19, 2004PCT Publication Number: WO2004/069141

International Family Members for US Patent 7,608,282

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation 2005127599 ➤ Try a Free Trial
Serbia 51696 ➤ Try a Free Trial
Serbia 20050600 ➤ Try a Free Trial
Portugal 1589956 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Deloitte
Fish and Richardson
Healthtrust
Cipla
Covington
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.